Jin Long Chen - Aug 9, 2021 Form 4 Insider Report for NGM BIOPHARMACEUTICALS INC (NGM)

Role
Chief Scientific Officer, Director
Signature
/s/ Jin-Long Chen
Stock symbol
NGM
Transactions as of
Aug 9, 2021
Transactions value $
-$714,222
Form type
4
Date filed
8/11/2021, 06:48 PM
Previous filing
Jul 29, 2021
Next filing
Sep 14, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NGM Common Stock Sale -$184K -7.73K -0.78% $23.81* 982K Aug 9, 2021 Direct F1, F2
transaction NGM Common Stock Sale -$168K -6.67K -0.68% $25.12* 975K Aug 9, 2021 Direct F1, F3
transaction NGM Common Stock Sale -$15.4K -600 -0.06% $25.62* 974K Aug 9, 2021 Direct F1, F4
transaction NGM Common Stock Sale -$347K -15K -1.54% $23.15* 959K Aug 10, 2021 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 6, 2021.
F2 Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $23.44 to $24.29. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $24.49 to $25.46. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
F4 Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $25.52 to $25.91. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
F5 Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $22.86 to $23.75. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range.